In his new role, Julien Elric will be backing founders developing new medicines for cancer and neurological diseases.
Julien Elric has taken on the position of senior investment director at Servier Ventures, the corporate VC arm of France-based pharmaceutical company Servier. He was previously senior principal at biopharma fund Jeito.
Elric will be looking to back founders developing new medicines for cancer and neurological diseases in his new role.
In his five years at Jeito, Elric was involved in multiple transactions across the investment lifecycle. Prior to that, he spent five and a half years at Institut de Cerveau in various roles, the most recent being incubator manager.
Servier Ventures was launched earlier this year with a commitment of $234m to boost innovation in the European biotech sector. The fund targets startups developing treatments for cancer and neurological conditions.
Do you have a star performer on your team?
We are looking for nominations for high-performing early and mid-career corporate venture professionals to honour in our annual awards.
Use this quick nomination form to suggest someone we should consider.
See all the recent European biopharma deals in the CVC Funding Round Database
Oishani Mitra
Oishani Mitra is the content manager for Global Corporate Venturing.
